Inncardio, Inc. Announces Agreement With Sigmoid Biotechnologies Ltd. NEW YORK, April 18 /PRNewswire-FirstCall/ -- Inncardio, Inc. (OTC:INDO) (BULLETIN BOARD: INDO) , a company founded by...
Inncardio, Inc. Announces Acquisition of Cengent Therapeutics, Inc. NEW YORK, April 1 /PRNewswire-FirstCall/ -- Inncardio, Inc. (OTC:INDO) (BULLETIN BOARD: INDO) , a company founded by...
Inncardio, Inc. Commences Trading on OTCBB Under Ticker 'INDO' NEW YORK, March 4 /PRNewswire-FirstCall/ -- Inncardio, Inc. (OTC:INDO) (BULLETIN BOARD: INDO) , a biotechnology company focused on...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales